V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280002909 | 280002204 | null | 83.7 | Curative (C) | 2018-01-02 | 2018-01-04 | Cetuximab + Radiotherapy Load | 2 | Y | 280024632 | CETUXIMAB + RT |
| 280002910 | 280002205 | 1.78 | 80.5 | Curative (C) | 2013-03-12 | 2013-03-24 | Cetuximab + Radiotherapy Load | N | N | 280024639 | CETUXIMAB + RT |
| 280002911 | 280002205 | 1.57 | 82.2 | Neo-adjuvant (N) | 2016-10-05 | 2016-10-25 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280024639 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280002912 | 280009691 | 1.71 | 65 | Neo-adjuvant (N) | 2014-09-20 | 2014-10-20 | Doxorubicin + Ifosfamide | N | N | 280024643 | DOXORUBICIN + IFOSFAMIDE |
| 280002913 | 280009691 | 1.58 | 92.2 | Neo-adjuvant (N) | 2016-12-31 | 2017-01-14 | Cisplatin +Fluorouracil (3 wk) | N | Y | 280024643 | CISPLATIN + FLUOROURACIL |
| 280002914 | 280002206 | 1.8 | 75.2 | Neo-adjuvant (N) | 2016-11-20 | 2016-11-22 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280024645 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280002915 | 280002207 | null | null | Neo-adjuvant (N) | 2017-08-22 | 2017-08-23 | Doxorubicin + Ifosfamide | N | N | 280024651 | DOXORUBICIN + IFOSFAMIDE |
| 280002916 | 280002208 | 1.64 | null | Neo-adjuvant (N) | 2017-01-27 | 2017-02-15 | Doxorubicin + Ifosfamide | N | N | 280024654 | DOXORUBICIN + IFOSFAMIDE |
| 280002917 | 280002209 | 1.6 | 103.8 | Palliative (P) | 2018-08-10 | 2018-08-10 | Cisplatin +Fluorouracil (3 wk) | 02 | null | 280024655 | CISPLATIN + FLUOROURACIL |
| 280002918 | 280002210 | 1.6 | 64 | Curative (C) | 2017-03-17 | 2017-04-04 | Cetuximab + Radiotherapy Load | N | Y | 280024656 | CETUXIMAB + RT |
| 280002919 | 280002211 | 1.58 | 65.5 | Neo-adjuvant (N) | 2015-10-05 | 2015-10-05 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280024657 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280002920 | 280002212 | 1.74 | 92 | Palliative (P) | 2014-11-28 | 2014-11-28 | Doxorubicin + Ifosfamide | N | N | 280024659 | DOXORUBICIN + IFOSFAMIDE |
| 280002921 | 280007200 | 1.86 | 89.2 | Curative (C) | 2013-10-02 | 2013-10-09 | CETUXIMAB + RT | N | Y | 280024660 | CETUXIMAB + RT |
| 280002922 | 280002213 | 1.82 | 97.5 | Adjuvant (A) | 2017-09-16 | 2017-10-15 | CETUXIMAB + RT | N | Y | 280024661 | CETUXIMAB + RT |
| 280002923 | 280002214 | 1.65 | 74.6 | Adjuvant (A) | 2017-08-19 | 2017-09-11 | Cetuximab + Radiotherapy Load | N | N | 280024662 | CETUXIMAB + RT |
| 280002924 | 280002215 | 1.61 | 72 | Neo-adjuvant (N) | 2013-03-16 | 2013-03-17 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280024665 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280002925 | 280002216 | 1.73 | 99 | Curative (C) | 2013-12-09 | 2013-12-12 | CETUXIMAB + RT | 01 | Y | 280024666 | CETUXIMAB + RT |
| 280002926 | 280002216 | 1.85 | 88 | Curative (C) | 2015-09-15 | 2015-10-07 | CETUXIMAB + RT | 02 | N | 280024666 | CETUXIMAB + RT |
| 280002927 | 280002217 | 1.88 | 78 | Curative (C) | null | 2013-03-25 | Cetuximab + Radiotherapy Load | N | Y | 280024669 | CETUXIMAB + RT |
| 280002928 | 280007202 | 1.59 | 120 | Neo-adjuvant (N) | 2014-08-05 | 2014-08-12 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280024670 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280002929 | 280007202 | 1.55 | 91.4 | Curative (C) | 2017-03-12 | 2017-04-12 | CETUXIMAB + RT | N | Y | 280024670 | CETUXIMAB + RT |
| 280002930 | 280002218 | 1.84 | 85.1 | Neo-adjuvant (N) | 2015-05-19 | 2015-05-19 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | null | 280024674 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280002931 | 280002219 | 1.8 | 66.2 | Neo-adjuvant (N) | 2016-04-20 | 2016-05-03 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280024676 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280002932 | 280007203 | 1.8 | 59.3 | Curative (C) | 2014-08-23 | 2014-08-25 | CETUXIMAB + RT | N | null | 280024677 | CETUXIMAB + RT |
| 280002933 | 280002220 | 1.8 | 101.7 | Palliative (P) | 2015-08-24 | 2015-08-29 | Doxorubicin + Ifosfamide | N | N | 280024679 | DOXORUBICIN + IFOSFAMIDE |
| 280002934 | 280002220 | 1.54 | 74.6 | Not known (9) | 2016-06-11 | 2016-07-02 | Cisplatin +Fluorouracil (3 wk) | N | N | 280024679 | CISPLATIN + FLUOROURACIL |
| 280002935 | 280002221 | 1.54 | null | Neo-adjuvant (N) | null | 2017-01-17 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 280024685 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280002936 | 280002221 | 1.61 | 69 | Palliative (P) | 2014-07-30 | 2014-07-30 | CISPLATIN + FLUOROURACIL | null | null | 280024685 | CISPLATIN + FLUOROURACIL |
| 280002937 | 280002222 | 1.61 | 64.6 | Not known (9) | 2017-12-24 | 2018-01-01 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 280024688 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280002938 | 280002223 | 1.75 | 56.7 | Curative (C) | 2017-05-10 | 2017-05-31 | Doxorubicin + Ifosfamide | N | N | 280024690 | DOXORUBICIN + IFOSFAMIDE |
| 280002939 | 280002224 | null | 91 | Neo-adjuvant (N) | 2016-12-11 | 2016-12-16 | Cisplatin +Fluorouracil (3 wk) | N | N | 280024691 | CISPLATIN + FLUOROURACIL |
| 280002940 | 280007206 | 168 | 83.75 | Curative (C) | 2014-12-28 | 2015-01-13 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280024692 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280002941 | 280002225 | 1.79 | 90.5 | null | null | 2015-09-25 | Doxorubicin + Ifosfamide | N | N | 280024695 | DOXORUBICIN + IFOSFAMIDE |
| 280002942 | 280007207 | 1.76 | null | Neo-adjuvant (N) | 2012-12-31 | 2013-01-28 | Doxorubicin + Ifosfamide | N | N | 280024696 | DOXORUBICIN + IFOSFAMIDE |
| 280002943 | 280007207 | 1.68 | null | Adjuvant (A) | 2014-01-01 | 2014-01-15 | Doxorubicin + Ifosfamide | 02 | N | 280024696 | DOXORUBICIN + IFOSFAMIDE |
| 280002944 | 280002226 | null | 62.6 | Palliative (P) | null | 2015-04-08 | CISPLATIN + FLUOROURACIL | null | null | 280024702 | CISPLATIN + FLUOROURACIL |
| 280002945 | 280002227 | 1.9 | 60.6 | Neo-adjuvant (N) | 2013-04-08 | 2013-05-06 | Cisplatin +Fluorouracil (3 wk) | N | N | 280024703 | CISPLATIN + FLUOROURACIL |
| 280002946 | 280002228 | 1.5 | 85 | Curative (C) | 2016-01-11 | 2017-01-07 | Cisplatin +Fluorouracil (3 wk) | N | N | 280024705 | CISPLATIN + FLUOROURACIL |
| 280002947 | 280007208 | 1.75 | null | Neo-adjuvant (N) | 2015-12-01 | 2015-12-02 | CISPLATIN + FLUOROURACIL | N | N | 280024706 | CISPLATIN + FLUOROURACIL |
| 280002948 | 280002229 | 1.6 | 66 | Neo-adjuvant (N) | 2018-02-11 | 2018-02-18 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280024709 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280002949 | 280002230 | 1.73 | 87.8 | Curative (C) | null | 2015-05-04 | CETUXIMAB + RT | null | Y | 280024710 | CETUXIMAB + RT |
| 280002950 | 280002230 | 1.8 | 93.6 | Neo-adjuvant (N) | 2017-12-22 | 2017-12-23 | Doxorubicin + Ifosfamide | N | N | 280024710 | DOXORUBICIN + IFOSFAMIDE |
| 280002951 | 280002231 | 1.63 | 80 | Neo-adjuvant (N) | 2016-09-03 | 2016-09-03 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 280024712 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280002952 | 280002232 | 1.5 | 68.5 | Curative (C) | 2016-12-29 | 2016-12-29 | Cetuximab + Radiotherapy Load | N | Y | 280024713 | CETUXIMAB + RT |
| 280002953 | 280007210 | 1.7 | 79.4 | Curative (C) | 2015-10-02 | 2015-10-08 | Cetuximab + Radiotherapy Maint | 02 | null | 280024714 | CETUXIMAB + RT |
| 280002954 | 280002233 | 1.9 | 70.4 | Curative (C) | 2015-03-11 | 2015-04-01 | Cetuximab + Radiotherapy Load | N | Y | 280024716 | CETUXIMAB + RT |
| 280002955 | 280002234 | 1.6 | 82.8 | Adjuvant (A) | null | 2016-02-04 | Doxorubicin + Ifosfamide | N | N | 280024717 | DOXORUBICIN + IFOSFAMIDE |
| 280002956 | 280002234 | null | 64.8 | Neo-adjuvant (N) | 2015-07-10 | 2015-07-24 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280024717 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280002957 | 280002235 | 1.74 | 100 | Palliative (P) | 2016-09-29 | 2016-10-28 | Cisplatin + Docetaxel +Fluorouracil | 01 | N | 280024719 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280002958 | 280002236 | 1.58 | 97.7 | Disease modification (D) | 2017-02-06 | 2017-02-15 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 280024720 | CISPLATIN + DOCETAXEL + FLUOROURACIL |